Ultrafiltration after cardiopulmonary bypass in children: Effects on hemodynamics, cytokines and complement

Cardiovascular Research

Volumn 31, Issue 4, 1996, Pages 596-602

  Saatvedt, K ^a   Lindberg, H ^a   Geiran, O R ^a   Michelsen, S ^a   Pedersen, T ^a   Seem, E ^a   Mollnes, T E ^b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b NORDLAND HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

cardiopulmonary bypass; complement system; cytokines; human; ultrafiltration

Indexed keywords

COMPLEMENT COMPONENT C3; CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HEART DISEASE; HEMODYNAMICS; HUMAN; PRIORITY JOURNAL; ULTRAFILTRATION;

CARDIOPULMONARY BYPASS; CHILD; COMPLEMENT C3A; COMPLEMENT C3B; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HEMODYNAMIC PROCESSES; HUMANS; INTERLEUKIN-6; POSTOPERATIVE PERIOD; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; ULTRAFILTRATION;

EID: 0029880746     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(95)00237-5     Document Type: Article

References (15)

1. Zobel G, Stein JL, Kuttnig M, Beitzke A, Metzler H, Rigler B. Continuous extracorporeal fluid removal in children with low cardiac output after cardiac operations. J Thorac Cardiovasc Surg 1991;101:593-97.
2. Elliot MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993;56:1518-22.
3. Naik SK, Knight A, Elliot M. A prospective randomized study of a modified technique of ultrafiltration during open heart surgery. Circulation 1991;84:422-31.
4. Andreasson S, Gøthberg S, Berggren H, Bengtsson A, Eriksson E, Risberg B. Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 1993;56: 1515-17.
5. Millar AB, Armstrong L, van der Linden J, Moat N, Ekroth R, Westwick J, Scallan M, Lincoln C. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993;56:1499-1502.
6. Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhe P, Safran D. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Anesthesiology 1994;81:1181-89.
7. Zilow G, Naser W, Rutz L, Burger R. Quantitation of anaphylatoxin C3a in the presence of C3 by a novel sandwich ELISA using monoclonal antibody to a C3a neoepitope. J Immunol Meth 1989;27:329-335.
8. Garred P, Mollnes TE, Lea T. Quantification in ELISA of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol 1988;27:329-35.
9. Mollnes TE, Lea T, Frøland S, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme linked immunosorbent assay based on monoclonal antibodies against neoantigen of the complex. Scand J Immunol 1985;22:197-202.
10. Gomez A, Wang R, Unruh H, Light RB, Bose D, Chau T, Correa E, Mink S. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990;73:671-85.
11. Stein B, Pfenninger E, Grunert A, Schmitz JE, Deller A, Kocher F. The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model. Intensive Care Med 1991;17:293-98.
12. Stein B, Pfenninger E, Grunert A, Schmitz JE, Huddle M. Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990;16:494-99.
13. Barrera P, Janssen EM, Demacker PN, Wetzels JF, van der Meer JW. Removal of interleukin-1 beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes. Lymphokine Cytokine Res 1992;11:1212-18.
14. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-57.
15. Mulvihill J, Cazenave JP, Mazzucotelli JP, Crost T, Collier C, Renaux JL, Pusineri C. Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophan and polysulphone hollow fibres. Biomaterials 1992;13:527-36.